Margret Z. Powell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Margret Z. Powell has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Carolyn E. Sartor
Institute for Health, Health Care Policy and Aging Research, Rutgers University, 112 Paterson Street, New Brunswick, NJ, 08901, USA.
3 shared publications - Nicole Kennelly
Institute for Health, Health Care Policy and Aging Research; Rutgers Addiction Research Center; Rutgers University, New Brunswick, NJ, USA
2 shared publications - Shawn J. Latendresse
Baylor University, Waco, TX, USA
2 shared publications - Tammy Chung
Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University; Institute for Health, Health Care Policy and Aging Research
2 shared publications - Agathe S. Ceppe
Marsico Lung Institute/Cystic Fibrosis Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
1 shared publication - Brian Handly
Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
1 shared publication
Latest Publications
- Open Access
- 6 April 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 179, 108702
Latent classes of substance use precursors predict positive alcohol and cannabis expectancies one year later in Black and Latino early adolescents in the ABCD study
- 6 April 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 179, 108702
Open AccessLatent classes of substance use precursors predict positive alcohol and cannabis expectancies one year later in Black and Latino early adolescents in the ABCD study
- 18 March 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (9) , 1519-1528
Measurement invariance in the Youth Electronic Cigarette Outcome Expectancies Questionnaire across sex and race/ethnicity in pre- to early adolescence
This study examined whether the Youth E-cigarette Outcome Expectancies Questionnaire (YEOEQ) measures e-cigarette beliefs consistently with respect to sex, race/ethnicity, and intersectional identity among Black, Latino, and White youth. Inconsistent measurement, or non-invariance, can lead to misleading conclusions about which groups are at higher risk of e-cigarette use. By identifying and adjusting for this bias, we aimed to improve the accuracy of group comparisons. Data were drawn from Follow-up 3 of the Adolescent Brain Cognitive Development Study (n=8,976; Mage=12.91, 47.27% female; 15.02% Black, 22.94% Latino, 62.03% White). Moderated nonlinear factor analysis was applied to the Positive and Negative Expectancies YEOEQ subscales. Mean subscale scores were compared across groups pre- and post-adjustment for non-invariance. Non-invariance by sex, race/ethnicity, and intersectional identity was observed at the item level for both subscales, and at the factor level for Positive Expectancies. For Positive Expectancies, adjusted comparisons revealed previously undetected lower scores among Black versus Latino (gadjusted=0.15) and White youth (gadjusted=0.16) and reduction to non-significance of previously observed higher scores for Latino versus White youth. For Negative Expectancies, observed lower scores for Black versus Latino youth (gunadjusted=0.15) and Latino versus White youth (gunadjusted=0.15) remained significant but effect sizes decreased when adjusted. Findings demonstrate measurement bias in the YEOEQ by sex and race/ethnicity in early adolescents. Unadjusted scores suggested riskier (more positive) e-cigarette expectancies among Latino than White youth and missed lower risk (less positive) among Black youth, potentially misguiding attention to these marginalized groups.
- 18 March 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (9) , 1519-1528
Measurement invariance in the Youth Electronic Cigarette Outcome Expectancies Questionnaire across sex and race/ethnicity in pre- to early adolescence
This study examined whether the Youth E-cigarette Outcome Expectancies Questionnaire (YEOEQ) measures e-cigarette beliefs consistently with respect to sex, race/ethnicity, and intersectional identity among Black, Latino, and White youth. Inconsistent measurement, or non-invariance, can lead to misleading conclusions about which groups are at higher risk of e-cigarette use. By identifying and adjusting for this bias, we aimed to improve the accuracy of group comparisons. Data were drawn from Follow-up 3 of the Adolescent Brain Cognitive Development Study (n=8,976; Mage=12.91, 47.27% female; 15.02% Black, 22.94% Latino, 62.03% White). Moderated nonlinear factor analysis was applied to the Positive and Negative Expectancies YEOEQ subscales. Mean subscale scores were compared across groups pre- and post-adjustment for non-invariance. Non-invariance by sex, race/ethnicity, and intersectional identity was observed at the item level for both subscales, and at the factor level for Positive Expectancies. For Positive Expectancies, adjusted comparisons revealed previously undetected lower scores among Black versus Latino (gadjusted=0.15) and White youth (gadjusted=0.16) and reduction to non-significance of previously observed higher scores for Latino versus White youth. For Negative Expectancies, observed lower scores for Black versus Latino youth (gunadjusted=0.15) and Latino versus White youth (gunadjusted=0.15) remained significant but effect sizes decreased when adjusted. Findings demonstrate measurement bias in the YEOEQ by sex and race/ethnicity in early adolescents. Unadjusted scores suggested riskier (more positive) e-cigarette expectancies among Latino than White youth and missed lower risk (less positive) among Black youth, potentially misguiding attention to these marginalized groups.
- 17 March 2026
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 61 (3)
Associations between alcohol-related parenting factors and youth alcohol expectancies: considering the role of perceived friends’ disapproval of alcohol use
We investigated variations in associations of alcohol-related parenting factors with alcohol expectancies by perceived friends’ disapproval of alcohol use in middle-school-aged youth (n = 7657). Perceived friend disapproval moderated the association of deciding on rules about drinking with positive expectancies. Parenting factors and friend disapproval were independently associated with negative expectancies.
- 17 March 2026
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 61 (3)
Associations between alcohol-related parenting factors and youth alcohol expectancies: considering the role of perceived friends’ disapproval of alcohol use
We investigated variations in associations of alcohol-related parenting factors with alcohol expectancies by perceived friends’ disapproval of alcohol use in middle-school-aged youth (n = 7657). Perceived friend disapproval moderated the association of deciding on rules about drinking with positive expectancies. Parenting factors and friend disapproval were independently associated with negative expectancies.
- Open Access
- 19 October 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (20) , 6160
Dynamic Perfluorinated Gas MRI Shows Improved Lung Ventilation in People with Cystic Fibrosis after Elexacaftor/Tezacaftor/Ivacaftor: An Observational Study
The availability of highly effective CFTR modulators is revolutionizing the treatment of cystic fibrosis (CF) and drastically improving outcomes. MRI-based imaging modalities are now emerging as highly sensitive endpoints, particularly in the setting of mild lung disease. Adult CF patients were recruited from a single center prior to starting treatment with E/T/I. The following studies were obtained before and after one month on treatment: spirometry, multiple breath nitrogen washout (MBW), 1H UTE MRI (structural images) and 19F MRI (ventilation images). Changes between visits were calculated, as were correlations between FEV1, lung clearance index (LCI), MRI structural scores, and MRI-based ventilation descriptors. Eight subjects had complete datasets for evaluation. Consistent with prior clinical trials, FEV1 and LCI improved after 28 days of E/T/I use. 1H UTE MRI detected improvements in bronchiectasis/airway wall thickening score and mucus plugging score after 28 days of therapy. 19F MRI demonstrated improvements in fractional lung volume with slow gas washout time (FLV↑tau2) and ventilation defect percentage (VDP). Improvements in FLV↑tau2 and VDP correlated with improvement in FEV1 (r = 0.81 and 0.86, respectively, p < 0.05). This observational study establishes the ability of 19F MRI and 1H UTE MRI to detect improvements in lung structure and function after E/T/I treatment. This study supports further development of 19F MRI and 1H UTE MRI as outcome measures for cystic fibrosis research and drug development.
- 19 October 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (20) , 6160
Open AccessDynamic Perfluorinated Gas MRI Shows Improved Lung Ventilation in People with Cystic Fibrosis after Elexacaftor/Tezacaftor/Ivacaftor: An Observational Study
The availability of highly effective CFTR modulators is revolutionizing the treatment of cystic fibrosis (CF) and drastically improving outcomes. MRI-based imaging modalities are now emerging as highly sensitive endpoints, particularly in the setting of mild lung disease. Adult CF patients were recruited from a single center prior to starting treatment with E/T/I. The following studies were obtained before and after one month on treatment: spirometry, multiple breath nitrogen washout (MBW), 1H UTE MRI (structural images) and 19F MRI (ventilation images). Changes between visits were calculated, as were correlations between FEV1, lung clearance index (LCI), MRI structural scores, and MRI-based ventilation descriptors. Eight subjects had complete datasets for evaluation. Consistent with prior clinical trials, FEV1 and LCI improved after 28 days of E/T/I use. 1H UTE MRI detected improvements in bronchiectasis/airway wall thickening score and mucus plugging score after 28 days of therapy. 19F MRI demonstrated improvements in fractional lung volume with slow gas washout time (FLV↑tau2) and ventilation defect percentage (VDP). Improvements in FLV↑tau2 and VDP correlated with improvement in FEV1 (r = 0.81 and 0.86, respectively, p < 0.05). This observational study establishes the ability of 19F MRI and 1H UTE MRI to detect improvements in lung structure and function after E/T/I treatment. This study supports further development of 19F MRI and 1H UTE MRI as outcome measures for cystic fibrosis research and drug development.